NCI Considers Making Prevention Trial From NSABP; Other Groups Approached
In Brief: Connell Is President of Komen Foundation; Ravikumar Moves to New Jersey Cancer Inst.
NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling
Fisher, Redmond Removed Fro Official posts At NSABP
Pittsburgh Reprimands Staff For Use of Univ. Resources In Mailing
R. Lee Clark, 87, M.D. Anderson Mastermind, dies
Women Surgeons: We Need Answers On Tamoxifin Now
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish
